STOCK TITAN

Aemetis (AMTX) director Lydia Beebe receives 14,500-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aemetis, Inc. director Lydia I. Beebe reported receiving a grant of common stock as board compensation. On 01/22/2026, she was awarded 14,500 shares of Aemetis common stock at $1.54 per share under the company’s Amended and Restated 2019 Stock Plan. Following this grant, she beneficially owns 214,286 common shares, held directly. The transaction reflects routine equity-based compensation for service on the Board of Directors.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Beebe Lydia I

(Last) (First) (Middle)
20400 STEVENS CREEK BLVD, SUITE 700

(Street)
CUPERTINO CA 95014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEMETIS, INC [ AMTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 01/22/2026 A 14,500 A $1.54 214,286 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of Common Stock pursuant to the Aemetis, Inc. Amended and Restated 2019 Stock Plan as compensation for service on the Board of Directors.
Remarks:
/s/Todd Waltz attorney-infact 01/28/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aemetis (AMTX) report for Lydia I. Beebe?

Aemetis director Lydia I. Beebe reported receiving 14,500 shares of common stock. The shares were granted on January 22, 2026, as equity compensation for her service on the Board under the Amended and Restated 2019 Stock Plan.

At what price were the Aemetis (AMTX) shares granted to Lydia I. Beebe?

The grant to Lydia I. Beebe was reported at a price of $1.54 per share. This price applies to the 14,500 shares of Aemetis common stock awarded as compensation for her role on the company’s Board of Directors.

How many Aemetis (AMTX) shares does Lydia I. Beebe own after this Form 4 transaction?

After the reported grant, Lydia I. Beebe beneficially owns 214,286 Aemetis common shares. These shares are held directly and include the additional 14,500 shares granted as compensation for her continued service on the company’s Board of Directors.

What is the purpose of the Aemetis (AMTX) stock grant to Lydia I. Beebe?

The 14,500-share grant to Lydia I. Beebe represents compensation for serving on Aemetis’ Board. It was issued under the Aemetis, Inc. Amended and Restated 2019 Stock Plan, which provides equity awards to directors as part of their overall compensation package.

Is Lydia I. Beebe an officer or major shareholder of Aemetis (AMTX)?

Lydia I. Beebe is identified as a director of Aemetis, Inc., not as an officer or 10% owner. The Form 4 lists her relationship solely as a director and reports equity compensation related to her board service, not a controlling ownership position.

Does the Aemetis (AMTX) Form 4 report any derivative securities for Lydia I. Beebe?

The filing shows no derivative securities transactions for Lydia I. Beebe. Table II, which would list options, warrants, or other derivatives, contains no entries, indicating this particular Form 4 relates only to a common stock grant.
Aemetis

NASDAQ:AMTX

AMTX Rankings

AMTX Latest News

AMTX Latest SEC Filings

AMTX Stock Data

105.92M
61.56M
7.33%
15.47%
7.35%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
CUPERTINO